Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goli Samimi

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Molecular Biosciences|May 20, 2015
Methylation of cell-free circulating DNA in the diagnosis of cancerKristina Warton, Goli Samimi
Cancer Letters|January 17, 2012
Epigenetic biomarkers in epithelial ovarian cancerBrian S Gloss, Goli Samimi
Cancer|March 24, 2017
Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?Goli Samimi, Lori M Minasian
Oncotarget|December 7, 2017
Traceback: leveraging archived biospecimens to identify mutation carriersGoli Samimi, Mark E Sherman
Cancers|May 4, 2026
Gynecologic Cancer: Risk Factors, Interception and PreventionGoli Samimi, Brandy Heckman-Stoddard
Cancer Chemotherapy and Pharmacology|September 20, 2005
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transportersGoli Samimi, Stephen B Howell
Endocrine-Related Cancer|January 15, 2016
Methylated circulating tumor DNA in blood: power in cancer prognosis and responseKristina Warton, Kate L Mahon, Goli Samimi
Cancer Epidemiology|June 1, 2025
Use of breast cancer risk reducing medications by breast cancer risk level in an older U.S. cohortPaul F Pinsky, Edward Sauter, Goli Samimi
Scientific Reports|July 4, 2015
INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell modelsKim Moran-Jones, Laura M Brown, Goli Samimi
Cancer Genetics|March 24, 2018
Comparison of 4 commercial kits for the extraction of circulating DNA from plasmaKristina Warton, Lisa-Jane Graham, Nicole Yuwono, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Molecular Biosciences|May 20, 2015
Methylation of cell-free circulating DNA in the diagnosis of cancerKristina Warton, Goli Samimi
Cancer Letters|January 17, 2012
Epigenetic biomarkers in epithelial ovarian cancerBrian S Gloss, Goli Samimi
Cancer|March 24, 2017
Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?Goli Samimi, Lori M Minasian
Oncotarget|December 7, 2017
Traceback: leveraging archived biospecimens to identify mutation carriersGoli Samimi, Mark E Sherman
Cancers|May 4, 2026
Gynecologic Cancer: Risk Factors, Interception and PreventionGoli Samimi, Brandy Heckman-Stoddard
Cancer Chemotherapy and Pharmacology|September 20, 2005
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transportersGoli Samimi, Stephen B Howell
Endocrine-Related Cancer|January 15, 2016
Methylated circulating tumor DNA in blood: power in cancer prognosis and responseKristina Warton, Kate L Mahon, Goli Samimi
Cancer Epidemiology|June 1, 2025
Use of breast cancer risk reducing medications by breast cancer risk level in an older U.S. cohortPaul F Pinsky, Edward Sauter, Goli Samimi
Scientific Reports|July 4, 2015
INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell modelsKim Moran-Jones, Laura M Brown, Goli Samimi
Cancer Genetics|March 24, 2018
Comparison of 4 commercial kits for the extraction of circulating DNA from plasmaKristina Warton, Lisa-Jane Graham, Nicole Yuwono, et al.
Pageof 8